Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Dyno Nobel Limited (DNL.AX)
Southbank, VIC, AU
Dyno Nobel Limited is a global provider and distributor of commercial explosives, with operations spanning the United States, Australia, and Mexico. The company's offerings include specialized packaged explosives such as Powermite cartridges and Dynosplit, utilized for pre-split blasting, as well as ammonium nitrates. It supplies industrial explosives, associated goods, and services to a broad array of sectors, including metal and mineral mining, quarrying, agriculture, general industry, oil and gas exploration, and the concrete and building materials industries. Dyno Nobel also participates in the export market. The firm, which was previously named Incitec Pivot Limited, rebranded as Dyno Nobel Limited in March 2025. Founded in 1831, its main corporate office is situated in Southbank, Australia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.56% | +9.66% | +7.32% | +7.65% | +0.57% | +9.66% | +34.35% | +28.47% | +28.47% | +28.47% | +28.47% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 2 | 0 |
| Hold | 6 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-29.7% Q1'26: +1.1% (vs Q1'24)
-
EPS growth Chemicals - Specialty: +13.2%+148.5% ★ Q1'26: +113.2% (vs Q1'24)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-3.0% Q1'26: +1.1% (vs Q1'24)
-
EBIT margin Chemicals - Specialty: +8.8%+9.3% ★ Q1'26: +9.5% (vs Q1'24)
-
ROIC Chemicals - Specialty: +5.6%+4.7% Q1'26: +8.9% (vs Q1'24)
-
Share dilution Chemicals - Specialty: +0.1%-3.1% ★ Q1'26: -7.1% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.21× Q1'26: 1.39× (vs Q1'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Sep 2024 actual |
Sep 2025 actual |
Sep 2026 11 Rev. Ana. 7 EPS Ana. |
Sep 2027 12 Rev. Ana. 8 EPS Ana. |
Sep 2028 12 Rev. Ana. 5 EPS Ana. |
Sep 2029 10 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
5.28B
est: 5.38B (-1.9%)
|
3.71B
est: 5.51B (-32.7%)
|
3.53B
3.08B – 4.06B
-35.9% YoY
|
3.43B
3.11B – 3.85B
-3.0% YoY
|
3.53B
3.53B – 3.54B
+3.0% YoY
|
3.50B
3.11B – 3.97B
-1.0% YoY
|
| EBITDA |
-190.20M
est: 771.73M (-124.6%)
|
628.30M
est: 790.31M (-20.5%)
|
506.69M
441.96M – 581.95M
-35.9% YoY
|
491.74M
446.09M – 552.41M
-3.0% YoY
|
506.51M
505.71M – 507.30M
+3.0% YoY
|
501.32M
445.69M – 569.71M
-1.0% YoY
|
| EBIT |
-535.20M
est: 399.66M (-233.9%)
|
344.20M
est: 409.28M (-15.9%)
|
262.40M
228.88M – 301.38M
-35.9% YoY
|
254.66M
231.02M – 286.08M
-3.0% YoY
|
262.31M
261.90M – 262.72M
+3.0% YoY
|
259.62M
230.81M – 295.04M
-1.0% YoY
|
| Net Income |
-310.90M
est: 344.15M (-190.3%)
|
145.50M
est: 435.68M (-66.6%)
|
290.14M
262.42M – 466.20M
-33.4% YoY
|
361.94M
335.94M – 387.94M
+24.7% YoY
|
416.72M
378.84M – 454.61M
+15.1% YoY
|
408.74M
349.78M – 481.25M
-1.9% YoY
|
| SGA |
1.34B
est: 1.33B (+0.6%)
|
1.25B
est: 1.36B (-8.1%)
|
873.99M
762.34M – 1.00B
-35.9% YoY
|
848.19M
769.46M – 952.84M
-3.0% YoY
|
873.67M
872.30M – 875.04M
+3.0% YoY
|
864.72M
768.77M – 982.69M
-1.0% YoY
|
| EPS |
-0.16
est: 0.18 (-187.2%)
|
0.08
est: 0.23 (-65.7%)
|
0.18
0.14 – 0.25
-21.5% YoY
|
0.19
0.18 – 0.21
+8.6% YoY
|
0.22
0.20 – 0.24
+13.1% YoY
|
0.22
0.19 – 0.26
-1.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | VanEck - S&P/ASX MidCap ETF MVE.AX | 1.84% | 6.04M | 0.45% |
| 2 | VanEck - Australian Resources ETF MVR.AX | 1.52% | 7.45M | 0.35% |
| 3 | VanEck - Australian Equal Weight ETF MVW.AX | 1.28% | 28.34M | 0.35% |
| 4 | Vanguard MSCI Australian Small Companies Index ETF VSO.AX | 1.25% | 10.01M | 0.30% |
| 5 | iShares Edge MSCI Australia Minimum Volatility ETF MVOL.AX | 1.17% | 248.4K | 0.30% |
| 6 | VanEck Agribusiness ETF MOO | 1.00% | 9.62M | 0.56% |
| 7 | VanEck - MSCI Australian Sustainable Equity ETF GRNV.AX | 0.92% | 1.50M | 0.35% |
| 8 | BetaShares - Australian Ex-20 Portfolio Diversifier ETF EX20.AX | 0.68% | 3.13M | 0.25% |
| 9 | Vanguard Australian Shares High Yield ETF VHY.AX | 0.60% | 31.68M | 0.25% |
| 10 | BetaShares - Geared Australian Equities Complex ETF GEAR.AX | 0.48% | 2.07M | 0.78% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mauro Neves de Moraes | MD, Chief Executive Officer & Director | 3M | male |
| Greg Hayne | President of Dyno Nobel Americas | 2M | male |
| Nitesh Naidoo BCOMPT | Chief Financial Officer | 220.0K | male |
| Stephenie De Nichilo | Chief HSE & Operations Excellence Officer | — | female |
| Stuart Sneyd | President - Dyno Nobel Asia Pacific | — | male |
| Sunil Salhotra | Chief Development & Sustainability Officer | — | male |
| Tatiana Rudometova | Chief Legal & Corporate Affairs Officer | — | female |
| Tom Dixon | Vice President of Investor Relations | — | — |
| Richard Brown | President of EMEA & LATAM | — | male |
| Rob Mill | Chief People Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DNL.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
